Should the use of probiotics in the preterm be routine?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 97, Issue 1, 2012, Pages

  Millar, Michael ^a   Wilks, Mark ^a   Fleming, Paul ^a   Costeloe, Kate ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD CULTURE; BLOODSTREAM INFECTION; DEATH; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HUMAN; INFANT MORTALITY; INFECTION RISK; LACTOBACILLUS; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; PATIENT SELECTION; PREMATURITY; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; STAPHYLOCOCCUS AUREUS; TREATMENT INDICATION; VERY LOW BIRTH WEIGHT;

CHILD DEVELOPMENT; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT CARE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINES; PROBIOTICS;

EID: 84455183768     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2009.178939     Document Type: Review

References (43)

1. Deshpande G, Rao S, Patole S, et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-30.
2. Tarnow-Mordi WO, Wilkinson D, Trivedi A, et al. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010;125:1068-70.
3. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5. (Pubitemid 17092151)
4. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010;125:1071-2.
5. Tannert C, Elvers HD, Jandrig B. The ethics of uncertainty. In the light of possible dangers, research becomes a moral duty. EMBO Rep 2007;8:892-6. (Pubitemid 47500467)
6. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:F354-8. (Pubitemid 37094250)
7. Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 2010;125:777-85.
8. Leaf A, Dorling J, Kempley S, et al. ADEPT - Abnormal Doppler Enteral Prescription Trial. BMC Pediatr 2009;9:63.
9. Goldin BR, Gorback SL. Clinical indications for probiotics: an overview. Clin Infect Dis 2008;146:S144-51.
10. Honeycutt TC, El Khashab M, Wardrop RM 3rd, et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 2007;8:452-8; quiz 464.
11. Luoto R, Matomäki J, Isolauri E, et al. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr 2010;99:1135-8.
12. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004;38:62-9. (Pubitemid 38045874)
13. De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-80. (Pubitemid 40365870)
14. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8.
15. Rougé C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009;89:1828-35.
16. Szajewska H, Shamir R. Is a meta-analytical approach appropriate to assess the efficacy of probiotics? Pediatrics 2010;125:921-30.
17. Huang YC, Chou YH, Su LH, et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118:469-74.
18. Mammina C, Di Carlo P, Cipolla D, et al. Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control 2007;35:222-30. (Pubitemid 46670516)
19. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997;76:F101-7. (Pubitemid 28201543)
20. Millar MR, Bacon C, Smith SL, et al. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993;69:483-7. (Pubitemid 23357107)
21. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003;74:89-96. (Pubitemid 37315841)
22. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;42:1735-42. (Pubitemid 43839439)
23. Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol 2006;44:4025-31. (Pubitemid 44737246)
24. Besselink MG, van Santvoort HC, Buskens E, et al.; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-9.
25. Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 2010;156:679-81.
26. Cotten CM, Taylor S, Stoll B, et al.; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
27. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:979-88. (Pubitemid 32285389)
28. Zhou JS, Pillidge CJ, Gopal PK, et al. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int J Food Microbiol 2005;98:211-17. (Pubitemid 40164946)
29. Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006;117:1979-87. (Pubitemid 46071242)
30. Desmond C, Stanton C, Fitzgerald GF, et al. Environmental adaptation of probiotic lactobacilli towards improvement of performance during spray drying. Int Dairy J 2001;11: 801-8. (Pubitemid 33146335)
31. Noriega L, de los Reyes-Gavilán CG, Margolles A. Acquisition of bile salt resistance promotes antibiotic susceptibility changes in bifidobacterium. J Food Prot 2005;68:1916-19.
32. Liberati A, D'Amico R, Pifferi S, et al. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009;4:CD000022.
33. Shiloh AL, Eisen LA, Savel RH. Selective decontamination of the digestive tract: what outcomes matter? Crit Care Med 2010;38:1386-7.
34. Oostdijk EA, de Smet AM, Blok HE, et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010;181:452-7.
35. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004;12:412-16. (Pubitemid 39178592)
36. Hehemann JH, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-12.
37. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310-18.
38. Gordon JI, Stappenbeck TS, Hooper LV. Response from Jeffrey I. Gordon et al.: Commensal bacteria make a difference. Trends Microbiol 2003;11:150-1. (Pubitemid 36428824)
39. Wilks M. Bacteria and early human development. Early Hum Dev 2007;83:165-70. (Pubitemid 46343773)
40. Siggers RH, Siggers J, Boye M, et al. Early administration of probiotics alters bacterial colonization and limits diet-induced gut dysfunction and severity of necrotizing enterocolitis in preterm pigs. J Nutr 2008;138:1437-44.
41. Houck PW, Nelson JD, Kay JL. Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs. Am J Dis Child 1972;123:45-8.
42. United Nations Environment Programme. Rio Declaration on Environment and Development, 1992. http://www.unep.org/Documents.Multilingual/Default.asp? documentID=78&articleID=1163.
43. Nuffield Council on Bioethics. Public Health: Ethical Issues. London: Cambridge Publishers, 2007.